Last C$2.60 CAD
Change Today +0.10 / 4.00%
Volume 18.5K
FRX On Other Exchanges
Symbol
Exchange
OTC US
Toronto
Frankfurt
As of 2:29 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

fennec pharmaceuticals inc (FRX) Snapshot

Open
C$2.52
Previous Close
C$2.50
Day High
C$2.60
Day Low
C$2.38
52 Week High
05/27/14 - C$7.77
52 Week Low
11/14/13 - C$0.63
Market Cap
25.4M
Average Volume 10 Days
6.7K
EPS TTM
C$-0.35
Shares Outstanding
9.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FENNEC PHARMACEUTICALS INC (FRX)

Related News

No related news articles were found.

fennec pharmaceuticals inc (FRX) Related Businessweek News

No Related Businessweek News Found

fennec pharmaceuticals inc (FRX) Details

Fennec Pharmaceuticals Inc., together with its subsidiaries, operates as a biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. Its lead product candidates include Sodium Thiosulfate, a water soluble thiol compound, which is in phase III clinical trials that act as a chemical reducing agent for the prevention of cisplatin induced hearing loss or ototoxicity in children; and Eniluracil, an oral irreversible dihydropyrimidine dehydrogenase inhibitor for the rapid break down of 5-FU in the body, which has completed phase II clinical trials for the treatment of metastatic breast cancer. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

1 Employees
Last Reported Date: 05/14/14
Founded in 1996

fennec pharmaceuticals inc (FRX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $140.0K
Interim Chief Financial Officer
Total Annual Compensation: $26.5K
Consultant
Total Annual Compensation: $71.5K
Compensation as of Fiscal Year 2013.

fennec pharmaceuticals inc (FRX) Key Developments

Adherex Technologies Inc. has Changed its Ticker to ADHXD from ADHX.F

Effective September 05, 2014, Adherex Technologies Inc. changed its Pink Sheets LLC stock ticker symbol to ADHXD from ADHX.F.

Fennec Pharmaceuticals Inc has Changed its Ticker to ADHXD from ADHX.F

Fennec Pharmaceuticals Inc changed its OTC Pink Current stock ticker symbol to ADHXD from ADHX.F.

Adherex Technologies Inc. has Changed its Name to Fennec Pharmaceuticals Inc

Adherex Technologies Inc. changed its name to Fennec Pharmaceuticals Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FRX:CN C$2.60 CAD +0.10

FRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FRX.
View Industry Companies
 

Industry Analysis

FRX

Industry Average

Valuation FRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FENNEC PHARMACEUTICALS INC, please visit www.fennecpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.